SynDaver Labs Expands Executive Leadership Team, Continues Growth, Prepares For IPO
TAMPA, Fla. – SynDaver Labs (http://syndaver.com) , a medical technology manufacturing company focused on the creation of high-fidelity synthetic human and animal simulators for medical and veterinary training, announced the expansion of their executive leadership team Monday with the hiring of Kevin King as their new vice president of global marketing.
“This is a great day for SynDaver, and I am very excited to have Kevin join my leadership team,” said Dr. Christopher Sakezles, founder of SynDaver Labs. “As we continue to experience record growth, the wisdom and expertise Kevin brings will be instrumental to our expansion as we continue progress towards our planned IPO.”
King, a native of Toronto, Canada, and an 18-year seasoned healthcare executive in the medical simulation marketplace, moved to the Tampa Bay area in 2015, where he served as a senior executive for CAE Healthcare, before joining SynDaver’s executive leadership team.
“SynDaver’s products are profoundly transformational in terms of medical education, and there’s nothing like them anywhere in the world, which is why I found SynDaver attractive,” King said. “Prior to my executive leadership roles, I have more than 15 years serving patients as a critical care paramedic in the air environment and on the ground, so patients and their outcomes are still fundamentally important to me. With SynDaver, I feel the company’s vision closely aligns with mine by providing the highest-fidelity simulated trainers to both human doctors and veterinarians so we can improve training and help save lives.”
Prior to his time at CAE, King worked for Muskoka EMS as chief of ambulance services and was adjunct faculty at METI in Sarasota as a critical care clinical educator.
SynDaver recently experienced a record-breaking second quarter and is expected to double their sales from last year. Additionally, this past January, SynDaver began executing plans to enable them to have an initial public offering, which is scheduled for 2020.
About SynDaver Labs (http://syndaver.com) Headquartered in Tampa, Florida, SynDaver Labs is the world’s leading manufacturer of ultra-realistic, synthetic human and animal surgical trainers. SynDaver’s synthetic bodies simulate fully-functioning live organisms and are primarily used for training in schools, hospitals and military installations. SynDaver has the world’s largest database of live-tissue properties and all SynDaver tissues are made from water, salts and fibers. The company currently has 12 patents on these materials, processes and related products. Currently, SynDaver Labs employs more than 100 people at their Tampa facility and is planning additional facilities in the U.S., China, Europe and Latin America.
SynDaver Labs products have been lauded by industry experts and earned a cult following after appearances on ABC’s Shark Tank, MythBusters, Grey’s Anatomy, and the series finale of CSI. The company's models are also expected to feature prominently in multiple episodes of the upcoming MythBusters 2.0.
“This is a great day for SynDaver, and I am very excited to have Kevin join my leadership team,” said Dr. Christopher Sakezles, founder of SynDaver Labs. “As we continue to experience record growth, the wisdom and expertise Kevin brings will be instrumental to our expansion as we continue progress towards our planned IPO.”
King, a native of Toronto, Canada, and an 18-year seasoned healthcare executive in the medical simulation marketplace, moved to the Tampa Bay area in 2015, where he served as a senior executive for CAE Healthcare, before joining SynDaver’s executive leadership team.
“SynDaver’s products are profoundly transformational in terms of medical education, and there’s nothing like them anywhere in the world, which is why I found SynDaver attractive,” King said. “Prior to my executive leadership roles, I have more than 15 years serving patients as a critical care paramedic in the air environment and on the ground, so patients and their outcomes are still fundamentally important to me. With SynDaver, I feel the company’s vision closely aligns with mine by providing the highest-fidelity simulated trainers to both human doctors and veterinarians so we can improve training and help save lives.”
Prior to his time at CAE, King worked for Muskoka EMS as chief of ambulance services and was adjunct faculty at METI in Sarasota as a critical care clinical educator.
SynDaver recently experienced a record-breaking second quarter and is expected to double their sales from last year. Additionally, this past January, SynDaver began executing plans to enable them to have an initial public offering, which is scheduled for 2020.
About SynDaver Labs (http://syndaver.com) Headquartered in Tampa, Florida, SynDaver Labs is the world’s leading manufacturer of ultra-realistic, synthetic human and animal surgical trainers. SynDaver’s synthetic bodies simulate fully-functioning live organisms and are primarily used for training in schools, hospitals and military installations. SynDaver has the world’s largest database of live-tissue properties and all SynDaver tissues are made from water, salts and fibers. The company currently has 12 patents on these materials, processes and related products. Currently, SynDaver Labs employs more than 100 people at their Tampa facility and is planning additional facilities in the U.S., China, Europe and Latin America.
SynDaver Labs products have been lauded by industry experts and earned a cult following after appearances on ABC’s Shark Tank, MythBusters, Grey’s Anatomy, and the series finale of CSI. The company's models are also expected to feature prominently in multiple episodes of the upcoming MythBusters 2.0.